US 11679113
Anticancer treatment for uveal melanoma
granted A61KA61K31/5025A61K31/5355
Quick answer
US patent 11679113 (Anticancer treatment for uveal melanoma) held by The Regents of the University of California expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/5025, A61K31/5355, A61K48/005, A61P